Nonmodiable Factors
Prevention of Stroke
1. Incidence of stroke can be lessened by reduction of risk factors (above).
2. Keeping hypertension, cholesterol level, weight, and diabetes controlled
can go a long way in pre- venting strokes.
3. Smoking cessation is essential.
4. Emboli may be prevented with warfarin in individuals at high risk from
atrial brillation.
5. Aspirin or other antiplatelet agents help prevent abnormal clotting.
6. Carotid endarterectomy can be done in patients with carotid stenosis.
7. It is important to educate all patients about new treatments for stroke and
the potential for reversal of symptoms with the use of the thrombolytic
agent t-PA.
8. Patients must be educated about symptoms of stroke and the importance
of receiving emergency treatment within 3 hours to maximize the
potential for prevention of neurological decits. Too often patients ignore
early symptoms or delay calling for help. This delay can mean the
difference between leading a normal life and permanent disability.
Pathophysiology
When blood ow to any part of the brain is impeded as a result of a thrombus or
embolus, oxygen deprivation can lead to ischemia and eventually to infarction
(necrosis) of the cerebral tissue. If the neurons are ischemic only and have not
yet infarcted, the injury may be reversible. However, necrosis is irreversible. The
necrotic zone is surrounded by an ischemic zone called the penumbra.
The goal of acute stroke management is to salvage the ischemic penumbra.
Without prompt intervention, the entire ischemic penumbra can eventually
become an infarcted region.17 Damage to the brain tissue may also result from
localized vasogenic cerebral edema, which forms around the penumbra.
Ischemic Stroke
An ischemic stroke can be caused by embolism or thrombosis, with resulting
decreased perfusion Although any vessel may be involved, the bifurcation of the
common carotid artery into the internal and external branches is the most
common location for cerebral atherosclerosis and sub- sequent occlusion from an
embolism or thrombosis.
When arteries are narrowed due to atherosclerotic plaque, they can become
occluded (thrombotic stroke). If emboli break away from plaque, they can travel
and lodge in narrowed cerebral vessels (embolic stroke). Either case results in
ischemia or infarct of the brain cells that are per- fused by the affected vessel.
Emboli in the brain may be arterial or cardiac in origin. Patients in atrial
brillation can have small clots develop in the atria because the blood is not
ejected normally, and as a result pools. These clots can be ejected into the
circulation and become emboli.
Other commonly recognized cardiac sources for embolism include sinoatrial
disorder, recent acute myocardial infarction (AMI), subacute bacterial
endocarditis, cardiac tumors, and valve disorders. Most strokes of cardiac origin
occur in the rst weeks after AMI, but some risk for stroke remains for an
indenite time. Stroke due to decreased perfusion occurs with severe stenosis of
the carotid or basilar arteries, or with stenosis of the small deep arteries of the
brain. The smallest, most dis- tal vessels are affected rst, before the larger
proximal vessels, a process termed watershed infarction. People with diabetes
and hypertension have an increased risk for atherosclerosis and thrombosis.
Decreased perfusion may also occur from vasculitis, an inammatory condition
involving the cerebral blood vessels. Common causes of vasculitis are systemic
lupus erythematosus, bacterial or tuberculous meningitis, fungal infection, and
herpes zoster arteritis (arterial inammation).
Hemorrhagic Stroke
Hemorrhagic stroke is caused by the rupture of a cerebral blood vessel.
When a cerebral blood vessel ruptures, the brain tissue beyond the vessel does
not receive oxygen and nutrients and can die. Additional damage can occur to
the brain tissue surrounding the rupture from blood being released in the brain
outside of the vascular system.
The most common cause of an intracerebral hemorrhage (ICH) is poorly
controlled hypertension. Another cause is a ruptured aneurysm. Hemorrhages
tend to occur deep within the brain tissue.
Subarachnoid hemorrhage (SAH) is caused by rupture of blood vessels on the
surface of the brain. This type of infarct has the slowest rate of recovery and the
highest probability of leaving the patient with extensive neurological decits.
The most common etiology of brain attack in younger patients is illicit drug
usage. PCP (phencyclidine), crack, cocaine, amphetamines, and heroin have all
been associated with cerebrovascular accident from subarachnoid or intracerebral hemorrhage because these drugs raise the blood pressure and increase
pressure within the cerebral vessels.
Risk Factors
Assessment
A stroke is usually characterized by the sudden onset of focal neurological
impairment. Speci c manifestations depend on the anatomical location of the
lesion.
Common signs and symptoms include
weakness,
numbness,
visual changes,
dysarthria,
dysphagia, or
aphasia
Scale Denition
0 = Normal.
1 = Partial gaze palsy; gaze is abnormal in one or both eyes.
2 = Forced deviation, or total gaze paresis not overcome by the
oculocephalic maneuver.
3. Visual: Visual elds (upper and lower quadrants) are tested by confrontation,
using nger counting or visual threat, as appropriate.
0 = No visual loss.
1 = Partial hemianopia.
2 = Complete hemianopia.
3 = Bilateral hemianopia (blind including cortical blindness).
4. Facial Palsy: Ask or use pantomime to encourage the patient to show teeth
or raise eyebrows and close eyes.
0 = Normal symmetrical movements.
1 = Minor paralysis ( attened nasolabial fold, asymmetry on smiling).
2 = Partial paralysis (total or near-total paralysis of lower face).
3 = Complete paralysis of one or both sides (absence of facial movement
in the upper and lower face).
5. Motor Arm: The limb is placed in the appropriate position: extend the arms
(palms down) 90 degrees (if sitting) or 45 degrees (if supine). Drift is scored if
the arm falls before 10 seconds. 5a. Left Arm 5b. Right Arm
0 = No drift; limb holds position for full 10 seconds.
1 = Drift; limb holds position, but drifts down before full 10 seconds; does
not hit bed or other support.
2 = Some effort against gravity; limb cannot get to or maintain (if cued)
position, drifts down to bed, but has some effort against gravity.
3 = No effort against gravity; limb falls.
4 = No movement. UN = Amputation or joint fusion.
6. Motor Leg: The limb is placed in the appropriate position: hold the leg at 30
degrees (always tested supine). Drift is scored if the leg falls before 5 seconds
. 6a. Left Leg
6b. Right Leg
0 = No drift; leg holds position for full 5 seconds.
1 = Drift; leg falls by the end of the 5-second period but does not hit bed.
2 = Some effort against gravity; leg falls to bed by 5 seconds, but has
some effort against gravity.
3 = No effort against gravity; leg falls to bed immediately.
Management
The management of an ischemic stroke has four primary goals:
Early Management
The focus of initial treatment is to save as much of the ischemic area as
possible.
Thrombolytic Therapy
Thrombolytic agents (eg, t-PA) dissolve clots and permit reperfusion of the brain
tissue. The history, neurological examination, NIHSS score, and results of
neuroimaging studies assist the physician with the decision to offer thrombolytic
therapy. Eligibility criteria for thrombolytic therapy are given in Box 23-4.
A major risk of this therapy is intracerebral hemorrhage. If the patient is a
candidate for thrombolytic therapy, the systolic blood pressure is maintained at
less than 185 mm Hg to the lower risk of hemorrhage. When t-PA is given, 10% of
the total dose (0.9 mg/kg, not to exceed 90 mg) is administered as an IV bolus
over 1 to 2 minutes, with the remainder infused over 60 minutes. No other
antithrombotic or antiplatelet therapy is given for the next 24 hours.
Interventional Radiology
Interventional radiology techniques include intra- arterial thrombolysis (ie, the
direct administration of t-PA to the site of the clot via the femoral artery) and the
use of mechanical clot removal devices (eg, the mechanical embolus removal for
cerebral ischemia, or MERCI retriever).
Intra-arterial thrombolysis can be given up to 6 hours after the onset of
symptoms
. Angiography is required, and the patient must be admitted or transferred to a
specialty center equipped to per- form the procedure.
Mechanical clot removal entails the use of a device that typically works like a
corkscrew to snare and remove the embolus.
Mechanical clot removal can be performed up to 8 hours after symptom onset
and even longer if obstruction involves the basilar artery. Eligibility criteria for
mechanical clot removal are given in Box 23-5. Potential complications include
bleeding and vascular dissection or perforation; close monitoring is required for
24 hours following the procedure to detect adverse effects.
Ongoing Management
A collaborative care guide for the patient who has had a stroke is given in Box
23-6. Supportive care measures include the following:
Anticoagulation therapy.
Antithrombotic and antiplatelet agents (eg, warfarin) may be administered to
prevent future thrombotic or embolic events.
Control of hypertension.
Patients with moderate hypertension usually are not treated acutely. If the
patient is not a candidate for thrombolytic therapy, the blood pressure is not
treated unless it exceeds 220 mm Hg systolic or 120 mm Hg diastolic because
reducing blood pressure reduces the CPP and can cause infarction of the penumbra. When necessary, blood pressure is lowered gradually using short-acting IV
antihypertensive agents.
Control of ICP.
Elevation of the ICP in a patient who has had a stroke, when it occurs, usually
occurs after the rst day. Measures to lower ICP are described in Chapter 22.
Control of blood glucose level.
Hyperglycemia and hypoglycemia can have potentially deleterious effects in
patients who have had a stroke.
Glycemic control may be achieved with a continuous insulin infusion or a slidingscale regimen.
INTERVENTIONS
Oxygenation/Ventilation
Adequate airway is maintained. SpO2 is maintained within normal
limits. Atelectasis is prevented.
Monitor breath sounds every shift.
Check oxygen saturation every shift.
Instruct patient to cough and deep breathe and use incentive spirometry
q2h while awake.
Assist with removal of airway secretions as needed.
Circulation/Perfusion Patient is free of dysrhythmias.
Monitor vital signs closely.
Skin Integrity
Patient has adequate caloric intake and does not experience decrease in
weight from baseline.
Patient is free from aspiration.
Obtain admission weight.
network is established.